# Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis

> **NCT01920919** · PHASE3 · UNKNOWN · sponsor: **St. Antonius Hospital** · enrollment: 76 (estimated)

## Conditions studied

- Sarcoidosis

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01920919
- **Lead sponsor:** St. Antonius Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-08
- **Final completion:** —
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2014-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920919, "Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01920919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*